Name: JOHNSON & JOHNSON (JNJ) Stock
Brand: JOHNSON & JOHNSON
Rating: 8 (3 reviews)

JNJ Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Chartmill - Mentions: AMZN GOOG AAPL NVDA ...

Wall Street Stumbles Ahead of Nvidia’s Big Moment

15 hours ago - By: The Motley Fool - Mentions: MDT PFE LLY ISRG

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

18 hours ago - By: The Motley Fool - Mentions: BMY BNTX

2 Top Dividend Stocks to Buy and Hold

2 days ago - By: Zacks Investment Research - Mentions: AZN PFE MRK

JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030

4 days ago - By: Zacks Investment Research - Mentions: BMY

BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised)

4 days ago - By: Bloomberg

Wall Street Optimism Pushes J&J Toward $500 Billion Market Value

4 days ago - By: Benzinga

What's Going On With Johnson & Johnson Stock On Wednesday?

4 days ago - By: Zacks Investment Research

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?

5 days ago - By: Zacks Investment Research - Mentions: BMY

BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi

7 days ago - By: BioMedWire - Mentions: OTLC IOVA MRK LLY

Biotech Valuations Rise as New Clinical Platforms Show Progress

9 days ago - By: Zacks Investment Research - Mentions: LLY NVDA ABBV PLTR

Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI

10 days ago - By: Zacks Investment Research - Mentions: HOLX BDX

Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?

10 days ago - By: Zacks Investment Research - Mentions: BMY PFE CYTK

Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio?

11 days ago - By: Zacks Investment Research - Mentions: LLY ABBV ADVM

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales

11 days ago - By: Benzinga

A Closer Look at Johnson & Johnson's Options Market Dynamics

11 days ago - By: Zacks Investment Research - Mentions: MRK UTHR

Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study

12 days ago - By: Zacks Investment Research - Mentions: AZN LLY ABBV

AbbVie Stock Rebounds After Q3 Dip: Time to Buy, Hold or Sell?

12 days ago - By: Zacks Investment Research

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

12 days ago - By: Zacks Investment Research - Mentions: ALKS FOLD

BAYRY Obtains Approval for Hormone Free VMS Treatment Lynkuet in the EU

12 days ago - By: Zacks Investment Research - Mentions: MDT ISRG

Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?

12 days ago - By: Zacks Investment Research - Mentions: PFE MRK CDTX

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B

12 days ago - By: Zacks Investment Research - Mentions: BIIB ABBV

Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3

13 days ago - By: Zacks Investment Research - Mentions: LLY ADVM

The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum

13 days ago - By: Investor's Business Daily - Mentions: PFE AZN

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment

14 days ago - By: Zacks Investment Research - Mentions: BMY CYTK BNTX

BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ

14 days ago - By: Zacks Investment Research - Mentions: CAT UNH M CACI ...

JOHNSON & JOHNSON (JNJ) Stock News